Abstract
Ten consecutive patients with failure of urinary bladder augmentation (UBA) performed either prior to or after reaching end-stage renal disease (ESRD) were studied. Seven patients developed increased hydroureteronephrosis, infectious complications, and advanced to ESRD after UBA. The mean time to development of ESRD in patients who had UBA performed with moderate chronic renal failure (CRF) was 1.8 years. The UBAs in all seven patients were taken down prior to transplantation. Subsequently, five of these UBA-takedown patients have received kidney grafts and all have stable, good renal function. Three patients had their UBA performed after they reached ESRD, in preparation for renal transplantation. All three of these patients experienced recurrent urosepsis following transplantation, resulting in death in one patient and loss of graft in another. The third patient will undergo takedown of the UBA. This study suggests that UBA may possibly not be the best option for patients with moderate CRF and those awaiting transplantation.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received December 3, 1996; received in revised form March 18, 1997; accepted March 27, 1997
Rights and permissions
About this article
Cite this article
Alfrey, E.J., Salvatierra, O., Tanney, D.C. et al. Bladder augmentation can be problematic with renal failure and transplantation. Pediatr Nephrol 11, 672–675 (1997). https://doi.org/10.1007/s004670050362
Published:
Issue Date:
DOI: https://doi.org/10.1007/s004670050362